| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |